Trilegal: Advises on Tynor Kedaara Capital $200M Investment

• Kedaara Capital invested $200 million to acquire a majority stake in Tynor Orthotics Private Limited.
• Trilegal advised Tynor, its promoters, management, and existing stakeholder Lighthouse Funds on the transaction.
• Quillon Partners provided legal counsel to Kedaara Capital for the investment.
• Tynor, founded in 1993, specializes in orthopaedic supports and has a global presence across 60 countries.
• Kedaara plans to collaborate with Tynor's founders to expand its market reach in India and internationally, alongside investing in manufacturing.

This substantial private equity investment signals continued robust M&A activity within India's burgeoning healthcare and orthotics sectors.

Kedaara Capital has finalized a substantial $200 million investment, securing a majority stake in Tynor Orthotics Private Limited. This significant Tynor Kedaara Capital $200M investment Trilegal advised transaction underscores a growing interest in India's specialized healthcare segments. Tynor, established in 1993, is a prominent player in the orthotics market, offering a diverse range of products including orthopaedic supports, mobility aids, rehabilitation equipment, and solutions for sports performance enhancement.

The company boasts an impressive global footprint, reaching over 300,000 retail outlets and 8,000 hospitals across 60 countries. Kedaara Capital's strategic move aims to collaborate closely with Tynor's promoters, Dr. P.J. Singh and Mr. A.J. Singh, to further expand the brand's presence. The partnership is set to deepen Tynor's market penetration across India, facilitate its expansion into new international territories, and drive investments in advanced, efficient manufacturing capabilities. This Tynor Orthotics acquisition highlights the potential for growth within the medical devices sector.

The intricate legal aspects of this major private equity transaction were managed by leading law firms, with Trilegal providing comprehensive counsel to Tynor, its promoters, the professional management team, and existing stakeholder Lighthouse Funds. The Trilegal Kedaara Capital deal saw a robust team spearheading the advisory efforts. Partners Amit Khansaheb, Vishruta Kaul, and Pratyush Singh led the core transaction team, supported by Counsel Aayush Sood, Senior Associates Advaye Sawhny and Neha Koppu, and Associates Mukund Agarwal, Akshat Jain, and Rohan Tolani.

On the other side of the table, Quillon Partners advised Kedaara Capital on its strategic investment. The Quillon Partners Tynor investment team was led by Partners Ankit Majmudar and Shriti Shah, ensuring Kedaara Capital's interests were expertly represented throughout the process. Additionally, specific real estate law considerations pertinent to the deal were addressed by Trilegal partners Rahul Arora and Yashasvi Gupta, alongside Consultant Shivek Jhanda. The collaboration between these legal powerhouses, particularly the Amit Khansaheb Ankit Majmudar deal leadership, exemplifies the specialized legal support required for large-scale India private equity M&A.

This substantial private equity investment signals continued robust M&A activity within India's burgeoning healthcare and orthotics sectors. The transaction provides valuable insights for corporate and private equity lawyers regarding current market valuations and potential deal structures in this dynamic environment. The commitment from Kedaara Capital to enhance Tynor's reach and manufacturing capabilities reflects a broader trend of strategic investments aimed at capitalizing on India's growing healthcare demand and export potential.

The collaboration between Kedaara Capital and Tynor's founders, Dr. P.J. Singh and Mr. A.J. Singh, is poised to accelerate Tynor's growth trajectory, both domestically and internationally. Such significant capital infusions are critical for companies looking to scale operations, innovate product lines, and strengthen their global competitive edge. This deal serves as a benchmark for future transactions in the Indian medical devices and healthcare services market, indicating a healthy appetite for well-established, globally-oriented businesses.

This significant private equity investment signals continued robust M&A activity in India's healthcare and orthotics sectors, providing insights for corporate and private equity lawyers on market valuations and potential deal structures. It also identifies key legal advisors at Trilegal and Quillon Partners active in large-scale Indian transactions.

Source: Original reporting via Bar & Bench